# Sprint Progress

Purpose: living progress board for the current change. Update it during each phase. Keep detailed verification evidence in phase artifacts such as `testing/results.md`.

Change ID: `20260619-phase2-card-api`
Status: request_analysis

## Phase Status

| Phase | Status | Notes |
|------|--------|-------|
| Request Analysis | Complete | Human approved. |
| Review | Complete | 3 blocking findings; F1 + F2 auto-fixed; F3 fallback path chosen (review_failed + actor override). |
| Implementation | Complete | 34 new TDD tests; repository + service + 7 route handlers shipped. No F2-02 / F2-03 / F2-04 / F-002 / F-003 / F-004 files modified. |
| Testing | Complete | Targeted 34 + regression 105 + full suite 485 all pass; typecheck 0 errors; lint 0 errors; format:check clean; diff --check clean. |
| Delivery | Complete | Implementation notes, testing results, delivery summary, and handoff written. |

## Current Focus

- None — F2-05 is delivered.

## Current Blockers

- None.

## Completed

- `request_analysis/spec.md` — 8 endpoint contract, auth matrix, error codes, deviation rationale.
- `request_analysis/tasks.md` — 15 sequenced TDD tasks.
- `request_analysis/feature_list.json` — F2-05 feature with 20 acceptance criteria + verification matrix; status: completed / passed / completed.
- `review/findings.md` — 3 blocking findings (F1, F2, F3), 13 non-blocking risks (R1–R13), 15 missing tests (MT1–MT15), 4 open questions (Q1–Q4).
- `implementation/notes.md` — files changed, reuse summary, deviations, risks, verification.
- `testing/results.md` — test diff and verification matrix.
- `delivery/summary.md` — feature summary + commit message suggestion.
- `handoff.md` — F2-06 / F2-08 handoff with realtime event names + audit entity type constants.

## Next Step

- Resume Phase 2 line at F2-06 (Human Confirmation API). No F2-05 follow-ups required.

## Change Log

- `2026-06-19`: Sprint progress created for F2-05 request analysis.
- `2026-06-19`: Phase 1 artifacts drafted.
- `2026-06-19`: Human approved Phase 1.
- `2026-06-19`: Phase 2 Review completed; 3 blocking findings, 13 non-blocking risks, 15 missing tests.
- `2026-06-20`: Human approved Phase 2; F3 fallback path chosen (no F-002 modification).
- `2026-06-20`: F2-05 implementation completed via TDD; 34 new tests green; 485/485 total.
- `2026-06-20`: F2-05 delivered; handoff points to F2-06.